Literature DB >> 15669920

Evidence for the occurrence of membrane-type serine protease 1/matriptase on the basolateral sides of enterocytes.

Satoshi Tsuzuki1, Nobuhito Murai, Yuka Miyake, Kuniyo Inouye, Hirofumi Hirayasu, Toshihiko Iwanaga, Tohru Fushiki.   

Abstract

MT-SP1 (membrane-type serine protease 1)/matriptase is an epithelial-derived integral membrane enzyme. The purpose of the present study was to examine whether the enzyme exists on the basolateral side of simple columnar epithelial cells, such as enterocytes, of normal adult animals. Using COS-1 monkey kidney cells transiently transfected with rat MT-SP1/matriptase expression plasmids, we found that the enzyme is post-translationally processed by the cleavage between Gly149 and Ser150, that a portion of the C-terminal part (Ser150-Val855) remains in the cells by association with the NTF (N-terminal fragment) (Met1-Gly149), while the other portions are released into the medium and that the release is increased on activation by co-expression with hepatocyte growth factor activator inhibitor type-1. Western-blot analysis of crude membranes prepared from rat jejunum demonstrated the presence of the NTF but negligible or no occurrence of the C-terminal part of the protein. Fractionation of the crude membranes by ultracentrifugation with Percoll followed by Western-blot analysis showed that the fractionation profile of the NTF correlated significantly with that of E-cadherin, an adhesion molecule on the lateral membrane. Immunostaining of the jejunum demonstrated the occurrence of the NTF on the lateral membranes but not on the apical membranes. These results suggest that considerable MT-SP1/matriptase molecules occur on the basolateral sides of normal epithelial cells and support our hypothesis that a possible physiological function of this enzyme is the control of epithelial-cell turnover by regulating cell-cell and/or cell-substratum adhesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15669920      PMCID: PMC1138976          DOI: 10.1042/BJ20041639

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

Review 1.  Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins.

Authors:  M D Resh
Journal:  Biochim Biophys Acta       Date:  1999-08-12

Review 2.  Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes.

Authors:  J D Hooper; J A Clements; J P Quigley; T M Antalis
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

3.  The p85 subunit of phosphoinositide 3-kinase is associated with beta-catenin in the cadherin-based adhesion complex.

Authors:  R J Woodfield; M N Hodgkin; N Akhtar; M A Morse; K J Fuller; K Saqib; N T Thompson; M J Wakelam
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

4.  Characterization of a membrane-bound arginine-specific serine protease from rat intestinal mucosa.

Authors:  K Kishi; K Yamazaki; I Yasuda; N Yahagi; M Ichinose; Y Tsuchiya; S B Athauda; H Inoue; K Takahashi
Journal:  J Biochem       Date:  2001-09       Impact factor: 3.387

5.  Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates.

Authors:  T Takeuchi; J L Harris; W Huang; K W Yan; S R Coughlin; C S Craik
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

6.  TGN38 cycles via the basolateral membrane of polarized Caco-2 cells.

Authors:  B J Reaves; E P Roquemore; J P Luzio; G Banting
Journal:  Mol Membr Biol       Date:  1998 Jul-Sep       Impact factor: 2.857

7.  Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue.

Authors:  T Takeuchi; M A Shuman; C S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

8.  Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues.

Authors:  H Kataoka; T Suganuma; T Shimomura; H Itoh; N Kitamura; K Nabeshima; M Koono
Journal:  J Histochem Cytochem       Date:  1999-05       Impact factor: 2.479

9.  A role for membrane-type serine protease (MT-SP1) in intestinal epithelial turnover.

Authors:  S Satomi; Y Yamasaki; S Tsuzuki; Y Hitomi; T Iwanaga; T Fushiki
Journal:  Biochem Biophys Res Commun       Date:  2001-10-05       Impact factor: 3.575

10.  Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease.

Authors:  S L Lee; R B Dickson; C Y Lin
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

View more
  16 in total

1.  Transport via the transcytotic pathway makes prostasin available as a substrate for matriptase.

Authors:  Stine Friis; Sine Godiksen; Jette Bornholdt; Joanna Selzer-Plon; Hanne Borger Rasmussen; Thomas H Bugge; Chen-Yong Lin; Lotte K Vogel
Journal:  J Biol Chem       Date:  2010-12-10       Impact factor: 5.157

Review 2.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

3.  Requirement of the activity of hepatocyte growth factor activator inhibitor type 1 for the extracellular appearance of a transmembrane serine protease matriptase in monkey kidney COS-1 cells.

Authors:  Yuka Miyake; Satoshi Tsuzuki; Makoto Yasumoto; Tohru Fushiki; Kuniyo Inouye
Journal:  Cytotechnology       Date:  2009-08-05       Impact factor: 2.058

Review 4.  Membrane-anchored serine proteases in vertebrate cell and developmental biology.

Authors:  Roman Szabo; Thomas H Bugge
Journal:  Annu Rev Cell Dev Biol       Date:  2011-06-29       Impact factor: 13.827

5.  Roles of CUB and LDL receptor class A domain repeats of a transmembrane serine protease matriptase in its zymogen activation.

Authors:  Kuniyo Inouye; Marie Tomoishi; Makoto Yasumoto; Yuka Miyake; Kenji Kojima; Satoshi Tsuzuki; Tohru Fushiki
Journal:  J Biochem       Date:  2012-10-03       Impact factor: 3.387

6.  Identification of the matriptase second CUB domain as the secondary site for interaction with hepatocyte growth factor activator inhibitor type-1.

Authors:  Kuniyo Inouye; Satoshi Tsuzuki; Makoto Yasumoto; Kenji Kojima; Seiya Mochida; Tohru Fushiki
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

7.  Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1.

Authors:  Baoyu Zhao; Cai Yuan; Rui Li; Dan Qu; Mingdong Huang; Jacky Chi Ki Ngo
Journal:  J Biol Chem       Date:  2013-02-26       Impact factor: 5.157

8.  Prostasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway.

Authors:  Marguerite S Buzza; Erik W Martin; Kathryn H Driesbaugh; Antoine Désilets; Richard Leduc; Toni M Antalis
Journal:  J Biol Chem       Date:  2013-02-26       Impact factor: 5.157

9.  The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.

Authors:  Stine Friis; Katiuchia Uzzun Sales; Jeffrey Martin Schafer; Lotte K Vogel; Hiroaki Kataoka; Thomas H Bugge
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

10.  Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.

Authors:  Brian R Larsen; Simon D R Steffensen; Nis V L Nielsen; Stine Friis; Sine Godiksen; Jette Bornholdt; Christoffer Soendergaard; Annika W Nonboe; Martin N Andersen; Steen S Poulsen; Roman Szabo; Thomas H Bugge; Chen-Yong Lin; Hanne Skovbjerg; Jan K Jensen; Lotte K Vogel
Journal:  Exp Cell Res       Date:  2013-01-16       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.